Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 2/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.53 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.53 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.53 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | HTR2B | P41595 | 1/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.53 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azilsartan SCHEMBL30604716 | 0.88 | AGTR2 (0.68) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| Azilsartan SCHEMBL284893 | 0.88 | AGTR2 (0.68) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| SCHEMBL2716504 | 0.88 | AGTR2 (0.64) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| Azilsartan SCHEMBL7017842 | 0.87 | AGTR2 (0.67) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| Azilsartan SCHEMBL7017834 | 0.87 | AGTR2 (0.67) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| SCHEMBL18069705 | 0.86 | AGTR2 (0.52) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| SCHEMBL7015276 | 0.86 | AGTR2 (0.53) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| SCHEMBL2773417 | 0.85 | AGTR2 (0.57) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| Azilsartan SCHEMBL7017839 | 0.85 | AGTR2 (0.57) | AGTR2ABCB11EGFRERBB2CYP3A4 | |
| SCHEMBL7017670 | 0.85 | AGTR2 (0.59) | AGTR2ABCB11EGFRERBB2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2329812-B1 | FILM-COATED SCORED TABLET | TAKEDA PHARMACEUTICALS CO (JP) | 2017-09-06 | — | — | EP | claimed |
| EP-2428202-B1 | Orally disintegrating compositions | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi (TR) | 2015-07-01 | — | — | EP | claimed |
| EP-2586424-B1 | Pharmaceutical combinations comprising an angiotensin II receptor antagonist, hydrochlorothiazide and a disintegrant. | SANOVEL ILAC SANAYI VE TICARET (TR) | 2014-08-13 | — | — | EP | claimed |
| EP-1579872-B1 | BODY WEIGHT GAIN INHIBITOR | TAKEDA PHARMACEUTICAL (JP) | 2012-03-28 | — | — | EP | claimed |
| EP-1153613-B1 | PERCUTANEOUS ABSORPTION PREPARATIONS OF COMPOUND HAVING ANGIOTENSIN II RECEPTOR ANTAGONISM | TAKEDA PHARMACEUTICAL (JP) | 2010-11-10 | — | — | EP | claimed |
| EP-1197226-B1 | AGENTS FOR AMELIORATING TROUBLES FOLLOWING CEREBROVASCULAR FAILURE AND INHIBITING PROGRESS THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2007-11-21 | — | — | EP | claimed |
| EP-0914158-B2 | PHARMACEUTICAL COMBINATION CONTAINING A COMPOUND HAVING ANGIOTENSIN II ANTAGONISTIC ACTIVITY AND A COMPOUND WHICH INCREASES THE INSULIN-SENSITIVITY | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2006-01-25 | — | — | EP | claimed |
| EP-1197223-B1 | PREVENTIVES / REMEDIES / PROGRESSION INHIBITORS FOR SIMPLEX RETINOPATHY OR PREPROLIFERATING RETINOPATHY | TAKEDA PHARMACEUTICAL (JP) | 2005-02-16 | — | — | EP | claimed |
| EP-0914158-B1 | PHARMACEUTICAL COMBINATION CONTAINING A COMPOUND HAVING ANGIOTENSIN II ANTAGONISTIC ACTIVITY AND A COMPOUND WHICH INCREASES THE INSULIN-SENSITIVITY | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-07-10 | — | — | EP | claimed |